Phathom Pharmaceuticals, Inc. (PHAT)
8.36
-0.31
(-3.58%)
USD |
NASDAQ |
Sep 10, 13:28
Phathom Pharmaceuticals Total Assets (Quarterly) : 327.08M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 327.08M |
| March 31, 2026 | 305.12M |
| December 31, 2025 | 259.80M |
| September 30, 2025 | 240.29M |
| June 30, 2025 | 250.22M |
| March 31, 2025 | 294.21M |
| December 31, 2024 | 378.47M |
| September 30, 2024 | 387.04M |
| June 30, 2024 | 319.38M |
| March 31, 2024 | 356.50M |
| December 31, 2023 | 413.84M |
| September 30, 2023 | 236.99M |
| June 30, 2023 | 265.04M |
| March 31, 2023 | 144.01M |
| December 31, 2022 | 164.81M |
| September 30, 2022 | 201.93M |
| Date | Value |
|---|---|
| June 30, 2022 | 213.50M |
| March 31, 2022 | 149.05M |
| December 31, 2021 | 189.43M |
| September 30, 2021 | 228.38M |
| June 30, 2021 | 214.58M |
| March 31, 2021 | 246.36M |
| December 31, 2020 | 295.11M |
| September 30, 2020 | 230.89M |
| June 30, 2020 | 252.42M |
| March 31, 2020 | 263.92M |
| December 31, 2019 | 257.18M |
| September 30, 2019 | 79.71M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.902M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 671.35M |
| Shareholders Equity (Quarterly) | -344.27M |
| Debt to Equity Ratio | -1.603 |
| Current Ratio | 1.924 |
| Net Debt Paydown Yield | 0.29% |